---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Eye Chart Pro Remote Control"
developer_entity: "Dok LLC"
bundle_id: "com.dok.eyechartproremote"
app_store_id: "448853455"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2024-11-15"
report_date: "2026-06-25"
last_verified: "2026-06-25T00:00:00.000Z"
report_version: "2.0.1"
total_reviews: 5
overall_rating: 3
sentiment: "Frustrated"
sentiment_score: 25
confidence: "low"
confidence_score: 0.5
top_praise_theme: "The core eye chart functionality provides a usable free tool for basic clinical vision testing"
top_complaint_theme: "Remote control connectivity fails consistently between devices after recent operating system updates"
review_sample_size: 8
total_review_count: 8
analyzed_review_count: 8
data_age_days: 52
momentum_velocity: "zombie"
intelligence_version: 4
competitor_count: 6
tags: ["medical", "freemium", "frustrated sentiment", "mobile app", "app review", "app analysis", "professionals", "clinicians", "using"]
canonical_url: "https://marlvel.ai/apps/eye-chart-pro-remote-control"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Eye Chart Pro Remote Control Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Freemium
- **Signal**: Rating 3 · Sentiment Frustrated
- **Recent focus**: Remote control connectivity fails consistently between devices after recent operating system updates (top complaint) · The core eye chart functionality provides a usable free tool for basic clinical vision testing (top praise)

> **TL;DR:** Eye Chart Pro Remote Control is a medical app by Dok LLC, rated 3/5 by 5 users, with Frustrated user sentiment (25/100), available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Eye Chart Pro Remote Control faces Frustrated user sentiment (3/5 from 5 reviews), with remote control connectivity fails consistently between devices after recent operating system updates as the primary user concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 3/5 (5 reviews) |
| **User Mood** | Frustrated |
| **Category** | Medical |
| **Developer** | Dok LLC |
| **Pricing** | Freemium |
| **Platforms** | iOS |
| **Confidence** | Low (0.5/1.0) |
| **Data Age** | 52d |

## Metadata & Market Performance
- **Publisher:** Dok LLC
- **Category:** Medical
- **Target Audience:** Eye care professionals and clinicians using iPad-based vision testing software.
- **Platforms:** iOS
- **Version Reviewed:** 2.0.1
- **Report Date:** 2026-06-25
- **Signal Count:** 8 reviews analyzed
- **Confidence:** Low (0.5/1.0)
- **App Store ID (iOS):** 448853455
- **Bundle ID:** com.dok.eyechartproremote
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-06-25

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Eye Chart Pro Remote Control is a companion utility for iPad-based vision testing, allowing clinicians to manage charts via iPhone.
**Why users hire it:** Clinicians hire this app to enable wireless control of vision charts, reducing the need for manual interaction with the primary display device during patient exams.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Remote Control Functionality:** Turns iPhone or iPod Touch into a wireless controller for iPad-based eye charts.
- **[Standard] Cross-App Integration:** Connects with Eye Chart Pro, Eye Chart Premium, and Eye Chart Professional iPad apps.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Basic] Unlockable Functionality:** Access to advanced remote control features via the primary iPad app.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app maintains a 3-star rating across 8 reviews, reflecting significant stability issues. The lack of recent functional updates relative to the competitive landscape signals a loss of market relevance.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free remote control preview, Unlockable advanced functionality via primary iPad app
- **Analysis:** Freemium model uses the remote app as a free utility to drive adoption of the primary paid iPad medical software.

<!-- section:sentiment -->
## 🔴 User Sentiment (Low Confidence: 8 of 8 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 3/5
- **Platform Split:** iOS 3.0/5 (5 ratings)
- **Overall Sentiment:** Frustrated

### Top Praises
- **The core eye chart functionality provides a usable free tool for basic clinical vision testing**

### Top Complaints (Impact Areas)

- **Remote control connectivity fails consistently between devices after recent operating system updates**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Cross-app integration functions as a suite-retention mechanism for clinical practices

**Growth Levers:**
- Visual feedback integration on remote interface to match main display


<!-- /section:swot -->
## Recent Changes (v3 → v4) {#recent-changes}

The app's competitive position has declined due to critical connectivity failures and user reports of deceptive monetization, shifting the outlook from stable to declining.

**Overall trend**: Declining
**Compared at**: 2026-06-25

### High-impact changes
- **[Declined] Sentiment and Rating** (sentiment)
- **[Added] Connectivity Failures** (swot)
- **[Shifted] Outlook Trend** (outlook)

### Medium-impact changes
- **[Added] Monetization Complaints** (sentiment)
- **[Shifted] Competitive Landscape** (swot)

<!-- section:whats-new -->
## What's New

- **Latest (v2.0.1, 1 years ago):** General bug fixes.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Ships only minor bug fixes.
- No new features released recently.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 546 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Eye Chart Pro Remote Control is a medical app that is free with in-app purchases.
With a 3/5 rating from 5 reviews, it faces significant user friction.

<!-- speakable-start -->
> **Bottom Line:** The app provides essential clinical utility but suffers from critical connectivity failures, so the PM must prioritize a stability audit to prevent further erosion of the professional user base.
<!-- speakable-end -->

**Best for:** Eye care professionals and clinicians using iPad-based vision testing software.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Rebuild connectivity module because remote control failure is the #1 complaint → restore core clinical utility
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors


- Real-time visual feedback on remote (available in user requests but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The clinical vision testing market is shifting toward web-based, hardware-agnostic solutions that offer higher reliability. This app remains exposed due to its reliance on outdated multi-device connectivity, so revenue growth is unlikely without a fundamental shift in technical architecture.

- 🔴 Persistent connectivity failures between devices after OS updates erode clinical trust, leading to a declining user sentiment trend.
- 🔴 Deceptive monetization reports regarding feature access create long-term brand damage, which will likely accelerate churn to more reliable competitors.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 3/5 |
| Total Reviews | 5 |
| Sentiment | Frustrated (25/100) |
| Confidence | Low |
| Pricing Model | Freemium |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Eye Chart Pro Remote Control** (this app) | 3/5 | Frustrated | Dok LLC |
| [ASCO Member](https://marlvel.ai/apps/org-asco-memberapp) | N/A/5 | N/A | American Society of Clinical Oncology |
| [Simple Vision & Color Test](https://marlvel.ai/apps/jeongwookdongeun-checkeye) | 4.3/5 | N/A | BROKERS |
| [iVisionTester](https://marlvel.ai/apps/com-wilsonsn-ivisiontester) | 1.0/5 | N/A | Nicholas Wilson |
| [Color Blindness Test Ishihara](https://marlvel.ai/apps/color-blindness-test-ishihara) | 3.0/5 | N/A | Rina Katrina |
| [Vision Check by Optikos Prime](https://marlvel.ai/apps/vision-check-by-optikos-prime) | 5.0/5 | N/A | OptikosPrime ApS |

## Company Profile
- **Developer:** Dok LLC
- **Website:** [https://www.eyechartproapp.com/](https://www.eyechartproapp.com/)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/eye-chart-pro-remote-control/id448853455?uo=4)
- **Dev Site:** [Official Website](https://www.eyechartproapp.com/)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*ASCO Member*](https://marlvel.ai/apps/org-asco-memberapp) (American Society of Clinical Oncology) · N/A Rating
- [*Simple Vision & Color Test*](https://marlvel.ai/apps/jeongwookdongeun-checkeye) (BROKERS) · 4.3/5 Rating
- [*iVisionTester*](https://marlvel.ai/apps/com-wilsonsn-ivisiontester) (Nicholas Wilson) · 1.0/5 Rating
- [*Color Blindness Test Ishihara*](https://marlvel.ai/apps/color-blindness-test-ishihara) (Rina Katrina) · 3.0/5 Rating
- [*Vision Check by Optikos Prime*](https://marlvel.ai/apps/vision-check-by-optikos-prime) (OptikosPrime ApS) · 5.0/5 Rating
- [*vision.app*](https://marlvel.ai/apps/vision-app) (Capital Certainty SL) · N/A Rating
- [*Move On with AJ*](https://marlvel.ai/apps/move-on-with-aj) (Universal Relaxation Ltd) · 4.3/5 Rating | Positive Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/apps/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) · 4.6/5 Rating
- [*DeepScribe*](https://marlvel.ai/apps/deepscribe) (DeepScribe) · 4.0/5 Rating
- [*FHO+ Calc*](https://marlvel.ai/apps/ca-fhocalc-app) (Manu Kaushik) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 8
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 52 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/eye-chart-pro-remote-control)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.